Primary and secondary functions of HLA-E are determined by stability and conformation of the peptide-bound complexes

<p>MHC-E regulates NK cells by displaying MHC class Ia signal peptides (VL9) to NKG2A:CD94 receptors. MHC-E can also present sequence-diverse, lower-affinity, pathogen-derived peptides to T&nbsp;cell receptors (TCRs) on CD8<sup>+</sup>&nbsp;T&nbsp;cells. To understand t...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Walters, LC, Rozbesky, D, Harlos, K, Quastel, M, Sun, H, Springer, S, Rambo, RP, Mohammed, F, Jones, EY, McMichael, AJ, Gillespie, GM
Format: Journal article
Język:English
Wydane: Cell Press 2022
Opis
Streszczenie:<p>MHC-E regulates NK cells by displaying MHC class Ia signal peptides (VL9) to NKG2A:CD94 receptors. MHC-E can also present sequence-diverse, lower-affinity, pathogen-derived peptides to T&nbsp;cell receptors (TCRs) on CD8<sup>+</sup>&nbsp;T&nbsp;cells. To understand these affinity differences, human MHC-E (HLA-E)-VL9 versus pathogen-derived peptide structures are compared. Small-angle X-ray scatter (SAXS) measures biophysical parameters in solution, allowing comparison with crystal structures. For HLA-E-VL9, there is concordance between SAXS and crystal parameters. In contrast, HLA-E-bound pathogen-derived peptides produce larger SAXS dimensions that reduce to their crystallographic dimensions only when excess peptide is supplied. Further crystallographic analysis demonstrates three amino acids, exclusive to MHC-E, that not only position VL9 close to the &alpha;2 helix, but also allow non-VL9 peptide binding with re-configuration of a key TCR-interacting &alpha;2 region. Thus, non-VL9-bound peptides introduce an alternative peptide-binding motif and surface recognition landscape, providing a likely basis for VL9- and non-VL9-HLA-E immune discrimination</p>